246 related articles for article (PubMed ID: 34278936)
1. Evaluating the utility of therapeutic drug monitoring in the clinical use of small molecule kinase inhibitors: a review of the literature.
Fahmy A; Hopkins AM; Sorich MJ; Rowland A
Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):803-821. PubMed ID: 34278936
[No Abstract] [Full Text] [Related]
2. Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure.
Rowland A; van Dyk M; Mangoni AA; Miners JO; McKinnon RA; Wiese MD; Rowland A; Kichenadasse G; Gurney H; Sorich MJ
Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):31-49. PubMed ID: 27561659
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.
Cardoso E; Guidi M; Blanchet B; Schneider MP; Decosterd LA; Buclin T; Csajka C; Widmer N
Ther Drug Monit; 2020 Feb; 42(1):33-44. PubMed ID: 31479043
[TBL] [Abstract][Full Text] [Related]
4. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology.
Erku D; Schneider J; Scuffham P
Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005
[TBL] [Abstract][Full Text] [Related]
5. Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.
Verheijen RB; Yu H; Schellens JHM; Beijnen JH; Steeghs N; Huitema ADR
Clin Pharmacol Ther; 2017 Nov; 102(5):765-776. PubMed ID: 28699160
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology.
Janssen JM; Dorlo TPC; Steeghs N; Beijnen JH; Hanff LM; van Eijkelenburg NKA; van der Lugt J; Zwaan CM; Huitema ADR
Clin Pharmacol Ther; 2020 Sep; 108(3):494-505. PubMed ID: 32022898
[TBL] [Abstract][Full Text] [Related]
7. A novel approach for the simultaneous quantification of 18 small molecule kinase inhibitors in human plasma: A platform for optimised KI dosing.
van Dyk M; Miners JO; Kichenadasse G; McKinnon RA; Rowland A
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():17-26. PubMed ID: 27521531
[TBL] [Abstract][Full Text] [Related]
8. Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
Groenland SL; Mathijssen RHJ; Beijnen JH; Huitema ADR; Steeghs N
Eur J Clin Pharmacol; 2019 Sep; 75(9):1309-1318. PubMed ID: 31175385
[TBL] [Abstract][Full Text] [Related]
9. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.
Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A
Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190
[TBL] [Abstract][Full Text] [Related]
10. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
11. Applications and challenges in therapeutic drug monitoring of cancer treatment: A review.
Salman B; Al-Khabori M
J Oncol Pharm Pract; 2021 Apr; 27(3):693-701. PubMed ID: 33302823
[TBL] [Abstract][Full Text] [Related]
12. Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.
Yu H; Steeghs N; Nijenhuis CM; Schellens JH; Beijnen JH; Huitema AD
Clin Pharmacokinet; 2014 Apr; 53(4):305-25. PubMed ID: 24566736
[TBL] [Abstract][Full Text] [Related]
13. [Role of individualized dosing in oncology: are we there yet?].
Joerger M
Praxis (Bern 1994); 2013 Dec; 103(1):33-9. PubMed ID: 24393821
[TBL] [Abstract][Full Text] [Related]
14. On precision dosing of oral small molecule drugs in oncology.
Lyashchenko AK; Cremers S
Br J Clin Pharmacol; 2021 Feb; 87(2):263-270. PubMed ID: 32621551
[TBL] [Abstract][Full Text] [Related]
15. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.
Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK;
Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of oral targeted antineoplastic drugs.
Mueller-Schoell A; Groenland SL; Scherf-Clavel O; van Dyk M; Huisinga W; Michelet R; Jaehde U; Steeghs N; Huitema ADR; Kloft C
Eur J Clin Pharmacol; 2021 Apr; 77(4):441-464. PubMed ID: 33165648
[TBL] [Abstract][Full Text] [Related]
17. Current status and future outlooks on therapeutic drug monitoring of fluorouracil.
Schmulenson E; Zimmermann N; Mikus G; Joerger M; Jaehde U
Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1407-1422. PubMed ID: 35029518
[TBL] [Abstract][Full Text] [Related]
18. The past, present, and future of chemotherapy with a focus on individualization of drug dosing.
DeRidder L; Rubinson DA; Langer R; Traverso G
J Control Release; 2022 Dec; 352():840-860. PubMed ID: 36334860
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring in cancer--are we missing a trick?
Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Drug Monitoring of Protein Kinase Inhibitors in the Treatment of Non-small Cell Lung Cancer.
Staša J; Gregorová J; Slanař O; Šíma M
Prague Med Rep; 2023; 124(3):199-215. PubMed ID: 37736945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]